Voyager Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Voyager Therapeutics has a total shareholder equity of $330.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $426.0M and $95.7M respectively. Voyager Therapeutics's EBIT is $9.1M making its interest coverage ratio -0.5. It has cash and short-term investments of $345.4M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -0.5x |
| Cash | US$345.36m |
| Equity | US$330.31m |
| Total liabilities | US$95.73m |
| Total assets | US$426.04m |
Recent financial health updates
No updates
Recent updates
Voyager Therapeutics' Tracer Platform Targets CNS Market: Here's Why I'm Neutral
Nov 18Improved Revenues Required Before Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock's 27% Jump Looks Justified
Oct 17
Voyager Therapeutics: CNS Player In Early Stages Of A Turnaround
Aug 26Earnings Beat: Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 09Lacklustre Performance Is Driving Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Low P/S
Aug 08Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis
Jun 05There's No Escaping Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Muted Revenues Despite A 28% Share Price Rise
Mar 15Voyager Therapeutics: A Tortoise With A Shot At Making Gene Therapy Deliver Easier
Mar 08What Does The Future Hold For Voyager Therapeutics, Inc. (NASDAQ:VYGR)? These Analysts Have Been Cutting Their Estimates
Mar 04Voyager Therapeutics, Inc. (NASDAQ:VYGR) Surges 45% Yet Its Low P/S Is No Reason For Excitement
Jan 04Voyager stock rises as Pfizer opts to use AAV capsid for neurologic disease target
Oct 04Voyager Therapeutics hires new finance chief
Sep 07Voyager Therapeutics GAAP EPS of -$0.50 misses by $0.02
Aug 04Looking Back In On Voyager Therapeutics
Jun 08Need To Know: Analysts Just Made A Substantial Cut To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Estimates
May 12Voyager Does A Reboot After First Generation Failures
Mar 25Financial Position Analysis
Short Term Liabilities: VYGR's short term assets ($373.4M) exceed its short term liabilities ($44.2M).
Long Term Liabilities: VYGR's short term assets ($373.4M) exceed its long term liabilities ($51.5M).
Debt to Equity History and Analysis
Debt Level: VYGR is debt free.
Reducing Debt: VYGR had no debt 5 years ago.
Debt Coverage: VYGR has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: VYGR has no debt, therefore coverage of interest payments is not a concern.